Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Industrial Alliance: Buy rating and C$1.25 target for MBX

<< Previous

Bullboard Posts

Next >>

Comment by RazeKreationson Aug 11, 2022 8:40pm

117 Views

Post# 34890200

RE:RE:Industrial Alliance: Buy rating and C$1.25 target for MBX

wizzdumb wrote: Is there new report? Link anyone?

I have searched everywhere, but no luck finding a report other than the article posted. I would also like to see her analysis and how she arrived at that projection. I don't disagree with the report but would be nice to see the analysis. It may be increased again after 4th quarter results

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China